Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma : A Study in Primary Care. / Savran, Osman; Godtfredsen, Nina Skavlan; Sørensen, Torben; Jensen, Christian; Ulrik, Charlotte Suppli.

In: International Journal of Chronic Obstructive Pulmonary Disease, Vol. 15, 01.2020, p. 931-937.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Savran, O, Godtfredsen, NS, Sørensen, T, Jensen, C & Ulrik, CS 2020, 'Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care', International Journal of Chronic Obstructive Pulmonary Disease, vol. 15, pp. 931-937. https://doi.org/10.2147/COPD.S241561

APA

Savran, O., Godtfredsen, N. S., Sørensen, T., Jensen, C., & Ulrik, C. S. (2020). Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care. International Journal of Chronic Obstructive Pulmonary Disease, 15, 931-937. https://doi.org/10.2147/COPD.S241561

Vancouver

Savran O, Godtfredsen NS, Sørensen T, Jensen C, Ulrik CS. Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care. International Journal of Chronic Obstructive Pulmonary Disease. 2020 Jan;15:931-937. https://doi.org/10.2147/COPD.S241561

Author

Savran, Osman ; Godtfredsen, Nina Skavlan ; Sørensen, Torben ; Jensen, Christian ; Ulrik, Charlotte Suppli. / Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma : A Study in Primary Care. In: International Journal of Chronic Obstructive Pulmonary Disease. 2020 ; Vol. 15. pp. 931-937.

Bibtex

@article{8de446cc1e764b1f8eb878ae2f9d7465,
title = "Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care",
abstract = "Background and Objective: Inhaled corticosteroids (ICS) for COPD has been much debated. Our aim was to identify characteristics associated with prescribing ICS for patients with COPD alone compared to those with concomitant asthma in general practice. Patients and Methods: Participating general practitioners (GPs) (n=144) recruited patients with COPD (ICPC 2nd ed. code R95) currently prescribed ICS (ACT code R03AK and R03BA). Data, if available, on demographics, smoking habits, spirometry, COPD medica-tion, dyspnea score, and exacerbation history were retrieved from the medical records. Logistic regression analysis was used to identify possible differences in characteristics between patients with COPD alone compared to those having a concomitant diagnosis of asthma. Results: A total of 2.289 (45% males) COPD patients on ICS were recruited. Compared to patients with COPD alone (n=1.749), those with COPD and concomitant asthma (n=540) were younger (p<0.001), had higher BMI, higher FEV1/FVC ratio, higher blood eosinophil count and less life-time tobacco exposure (36 and 26 pack-years, respectively). Compared to COPD alone, logistic regression analysis showed that COPD with concomitant asthma was significantly associated to age (OR 0.94; CI 0.92 to 0.97; p<0.001), pack-years of smoking (OR 0.98; CI 0.97 to 0.99; p<0.001), FEV1%pred (OR 1.02; CI 1.00 to 1.03; p=0.005), and doctor-diagnosed depression (OR 2.59; CI 1.20 to 5.58; p=0.015). Conclusion: In COPD patients currently prescribed ICS, the presence of concomitant asthma was associated with being younger, having less tobacco exposure, more preserved lung function and a higher likelihood of doctor-diagnosed depression compared to COPD alone.",
keywords = "Concomitant asthma, COPD, General practice, Inhaled corticosteroids (ICS)",
author = "Osman Savran and Godtfredsen, {Nina Skavlan} and Torben S{\o}rensen and Christian Jensen and Ulrik, {Charlotte Suppli}",
year = "2020",
month = jan,
doi = "10.2147/COPD.S241561",
language = "English",
volume = "15",
pages = "931--937",
journal = "International Journal of COPD",
issn = "1176-9106",
publisher = "Dove Medical Press Ltd",

}

RIS

TY - JOUR

T1 - Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma

T2 - A Study in Primary Care

AU - Savran, Osman

AU - Godtfredsen, Nina Skavlan

AU - Sørensen, Torben

AU - Jensen, Christian

AU - Ulrik, Charlotte Suppli

PY - 2020/1

Y1 - 2020/1

N2 - Background and Objective: Inhaled corticosteroids (ICS) for COPD has been much debated. Our aim was to identify characteristics associated with prescribing ICS for patients with COPD alone compared to those with concomitant asthma in general practice. Patients and Methods: Participating general practitioners (GPs) (n=144) recruited patients with COPD (ICPC 2nd ed. code R95) currently prescribed ICS (ACT code R03AK and R03BA). Data, if available, on demographics, smoking habits, spirometry, COPD medica-tion, dyspnea score, and exacerbation history were retrieved from the medical records. Logistic regression analysis was used to identify possible differences in characteristics between patients with COPD alone compared to those having a concomitant diagnosis of asthma. Results: A total of 2.289 (45% males) COPD patients on ICS were recruited. Compared to patients with COPD alone (n=1.749), those with COPD and concomitant asthma (n=540) were younger (p<0.001), had higher BMI, higher FEV1/FVC ratio, higher blood eosinophil count and less life-time tobacco exposure (36 and 26 pack-years, respectively). Compared to COPD alone, logistic regression analysis showed that COPD with concomitant asthma was significantly associated to age (OR 0.94; CI 0.92 to 0.97; p<0.001), pack-years of smoking (OR 0.98; CI 0.97 to 0.99; p<0.001), FEV1%pred (OR 1.02; CI 1.00 to 1.03; p=0.005), and doctor-diagnosed depression (OR 2.59; CI 1.20 to 5.58; p=0.015). Conclusion: In COPD patients currently prescribed ICS, the presence of concomitant asthma was associated with being younger, having less tobacco exposure, more preserved lung function and a higher likelihood of doctor-diagnosed depression compared to COPD alone.

AB - Background and Objective: Inhaled corticosteroids (ICS) for COPD has been much debated. Our aim was to identify characteristics associated with prescribing ICS for patients with COPD alone compared to those with concomitant asthma in general practice. Patients and Methods: Participating general practitioners (GPs) (n=144) recruited patients with COPD (ICPC 2nd ed. code R95) currently prescribed ICS (ACT code R03AK and R03BA). Data, if available, on demographics, smoking habits, spirometry, COPD medica-tion, dyspnea score, and exacerbation history were retrieved from the medical records. Logistic regression analysis was used to identify possible differences in characteristics between patients with COPD alone compared to those having a concomitant diagnosis of asthma. Results: A total of 2.289 (45% males) COPD patients on ICS were recruited. Compared to patients with COPD alone (n=1.749), those with COPD and concomitant asthma (n=540) were younger (p<0.001), had higher BMI, higher FEV1/FVC ratio, higher blood eosinophil count and less life-time tobacco exposure (36 and 26 pack-years, respectively). Compared to COPD alone, logistic regression analysis showed that COPD with concomitant asthma was significantly associated to age (OR 0.94; CI 0.92 to 0.97; p<0.001), pack-years of smoking (OR 0.98; CI 0.97 to 0.99; p<0.001), FEV1%pred (OR 1.02; CI 1.00 to 1.03; p=0.005), and doctor-diagnosed depression (OR 2.59; CI 1.20 to 5.58; p=0.015). Conclusion: In COPD patients currently prescribed ICS, the presence of concomitant asthma was associated with being younger, having less tobacco exposure, more preserved lung function and a higher likelihood of doctor-diagnosed depression compared to COPD alone.

KW - Concomitant asthma

KW - COPD

KW - General practice

KW - Inhaled corticosteroids (ICS)

U2 - 10.2147/COPD.S241561

DO - 10.2147/COPD.S241561

M3 - Journal article

C2 - 32425518

AN - SCOPUS:85084042784

VL - 15

SP - 931

EP - 937

JO - International Journal of COPD

JF - International Journal of COPD

SN - 1176-9106

ER -

ID: 244233217